セルスペクト株式会社
Morioka, JP · 3 known investors
Cellspect develops next-generation clinical diagnostic reagents and in-vitro diagnostic products based on deep-tech, covering diagnostic technologies from biomarker discovery to treatment monitoring. It offers open-innovation partnerships with pharmaceutical companies and medical institutions, including point-of-testing and precision oncology products, based in Iwate, Japan.
Founders & leadership
TI
Takuya Iwabuchi代表取締役兼CEO (Representative Director & CEO)
WH
Wataru HojoExecutive Officer & CTO
Investors · 3
Frequently asked questions
- What does セルスペクト株式会社 do?
- Cellspect develops next-generation clinical diagnostic reagents and in-vitro diagnostic products based on deep-tech, covering diagnostic technologies from biomarker discovery to treatment monitoring. It offers open-innovation partnerships with pharmaceutical companies and medical institutions, including point-of-testing and precision oncology products, based in Iwate, Japan.
- Who founded セルスペクト株式会社?
- セルスペクト株式会社 was founded by Takuya Iwabuchi.
- Who are セルスペクト株式会社's investors?
- セルスペクト株式会社's investors include Tokyo University of Science Innovation Capital, Iwagin Business Creation Capital, Mitsubishi UFJ Capital.
- Where is セルスペクト株式会社 headquartered?
- セルスペクト株式会社 is headquartered in Morioka, JP.